Tris Pharma, Inc.

Tris Pharma Completes Its Facilities' Expansion, Receives FDA Clearance

Published in Medical Letter on the CDC and FDA, October 12th, 2008

Tris Pharma, a privately- owned, specialty pharmaceutical company, announced that the expansion to its state-of-the-art research and manufacturing facility in South Brunswick is complete. This capacity-building initiative is a significant milestone for the company, marking its continued growth and success as a partner and provider of innovative drug delivery technologies.

The expansion provides approximately 15,000 square feet of additional space to the company's premises and current FDA-compliant cGMP facility. It allows for additional commercial-scale equipment and a new, larger warehouse that frees up space for a high-speed packaging area. This continued growth...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2008-10-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry